Michael Reinking, senior market strategist at the New York Stock Exchange, joins J.D. Durkin to discuss the dollar hitting four-year lows, Fed expectations, and what investors are watching as major tech earnings begin.
Video Transcript +
J.D.: Michael Reinking is a good friend of ours here on the show. He is the senior market strategist at the NYSE. Thanks for being here to kick off the...
Adam Swick, Chief Growth Officer at Marathon Digital Holdings, joins Remy Blaire to discuss the bitcoin market and the upcoming bitcoin halving. They also discuss the state of crypto mining and regulation.
Michale Lohan, Chief Executive Officer at IDA Ireland, joins Remy Blaire to discuss Ireland's fintech innovations, investment, and economic outlook. They also analyze Ireland's competitive advantage in foreign direct investment (FDI).
Bitcoin miner Marathon plans to make purchase to offset costs rewards 'Halving'. Bitcoin ETFs are ''going to pass gold ETFs'', which hold nearly $100 billion in assets, a Bloomberg analyst predicts, and the first U.S. offshore wind farm is officially opened. Jane King with the latest from the Nasdaq.
Bitcoin falls after monster rally. Keurig's new coffee pods are plastic free & sustainable and U.K. high court says Australian Craig Wright is not Satoshi Nakamoto. Jane King with the latest from the Nasdaq.
Coinbase plans to offer $1 billion in convertible notes. U.S. probing the use of cryptocurrency before Israel attack by Hamas. Crypto miners pulling in more money than ever and global methane emissions near record high in 2023. Jane King with the latest from the Nasdaq
Chase CEO Jamie Dimon still does not like bitcoin but defends the right for people to own it. Academics question ESG studies that support investment and Goldman, BNY Mellon & others test blockchain network for capital markets. Jane King with the latest from the Nasdaq.
Diamond Lake Minerals (OTCMKS: DLMI) takes a 24% stake in Avrio to secure its registered digital financial market infrastructure for the tokenization of digital assets.
David Elsley, the President & CEO of Cardiol Therapeutics Inc. (Nasdaq: CRDL | TSX: CRDL), a company dedicated to healing the heart with innovative science, joins Vince Molinari to discuss their recent milestones to kick off 2024. Mr. Elsley shares the significance of Cardiol receiving the US FDA grant for Orphan Drug Designation for the company's lead drug candidate, CardiolRx™, aimed at treating pericarditis, including recurrent pericarditis. He speaks to the severity of recurrent pericarditis, characterized by symptoms that significantly impact patients' quality of life and physical activity. The FDA's decision to grant ODD underscores the potential of CardiolRx™ to improve the lives of individuals suffering from this condition. They discuss Cardiol's two ongoing Phase II clinical trials targeting rare diseases of recurrent pericarditis and acute myocarditis. Additionally, Mr. Elsley shares the market opportunity for the company’s potential treatment for heart failure – a leading cause of death and hospitalization in the developed world, with associated healthcare costs in the United States exceeding $30 billion annually.
Todd McDonald, Co-Founder and Chief Strategy Officer at R3, joins Remy Blaire to discuss understanding tokenization and real-world assets on the blockchain.
John Schaible, Chief Strategy Officer at AtlasClear Holdings, inc., joins Vince Molinari to discuss ringing the opening bell and the future of the company. Atlas Clear aims to create a more efficient platform for trading, and banking.
James Butterfill, Head of Research of CoinShares, joins Remy Blaire to discuss the Bitcoin price surge and the risks Bitcoin investors should be aware of.
Dan Novaes, Chief Executive Officer at Mode Mobile, joins Vince Molinari to discuss how Mode Mobile created a state-of-the-art smartphone device with built-in earning features.